REGENERATING MUSCLE FROM WITHIN Trademark

Trademark Overview


On Tuesday, April 16, 2024, a trademark application was filed for REGENERATING MUSCLE FROM WITHIN with the United States Patent and Trademark Office. The USPTO has given the REGENERATING MUSCLE FROM WITHIN trademark a serial number of 98502905. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 31, 2024. This trademark is owned by Satellos Bioscience Inc.. The REGENERATING MUSCLE FROM WITHIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical scientific research information in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Research and development in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Consulting services in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Development of computer software platforms in the fields of medical sciences, biochemistry and biotechnology, and pharmacology; Platform as a service (PAAS) featuring computer software platforms for use in cell imaging, cell...
regenerating muscle from within

General Information


Serial Number98502905
Word MarkREGENERATING MUSCLE FROM WITHIN
Filing DateTuesday, April 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical scientific research information in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Research and development in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Consulting services in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Development of computer software platforms in the fields of medical sciences, biochemistry and biotechnology, and pharmacology; Platform as a service (PAAS) featuring computer software platforms for use in cell imaging, cell analysis, drug discovery, and drug target discovery in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSatellos Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5J2J3
CA

Trademark Events


Event DateEvent Description
Tuesday, April 16, 2024NEW APPLICATION ENTERED
Tuesday, April 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Friday, May 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NON-FINAL ACTION WRITTEN